About Danaher
Danaher is a company based in Washington (United States) founded in 1969 was acquired by Screenverse in June 2021. The company has 63,000 employees as of December 31, 2024. Danaher has completed 46 acquisitions, including AVT, Abcam and Aldevron. Danaher offers products and services including Biotechnology Services, Diagnostics Tools, and Life Sciences Technologies. Danaher operates in a competitive market with competitors including GE Healthcare, Medtronic, Boston Scientific, CONMED and Johnson & Johnson, among others.
- Headquarter Washington, United States
- Employees 63000 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Danaher Corporation
-
Annual Revenue
$24.57 B (USD)2.9as on Dec 31, 2025
-
Net Profit
$3.61 B (USD)-7.31as on Dec 31, 2025
-
EBITDA
$7.14 B (USD)-5.29as on Dec 31, 2025
-
Latest Funding Round
$12.91 M (USD), Post-IPO
Apr 02, 2018
-
Investors
Bank of America
& 1 more
-
Employee Count
63000
as on Dec 31, 2024
-
Investments & Acquisitions
AVT
& 45 more
-
Acquired by
Screenverse
(Jun 30, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Danaher
Danaher is a publicly listed company on the NYSE with ticker symbol DHR in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Danaher
Danaher offers a comprehensive portfolio of products and services, including Biotechnology Services, Diagnostics Tools, and Life Sciences Technologies.
Accelerates development and commercialization of innovative therapies
Provides tools for precise and rapid health diagnoses
Supports innovations in cell therapies and fluid filtration
People of Danaher
Unlock access to complete
Unlock access to complete
Software Development Team
181 people
Leadership Team
160 people
Human Resources and Administration
106 people
Product Management Team
59 people
Legal and Compliance
47 people
Finance and Accounting
41 people
Sales and Marketing
27 people
Operations Team
21 people
Unlock access to complete
Funding Insights of Danaher
- Total Funding Total Funding
- Total Rounds 4
- Last Round Post-IPO — $12.9M
-
First Round
First Round
(22 Jan 2001)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2018 | Amount | Post-IPO - Danaher | Valuation |
investors |
|
| Mar, 2018 | Amount | Debt – Conventional - Danaher | Valuation |
investors |
|
| Sep, 2015 | Amount | Debt – Conventional - Danaher | Valuation |
investors |
|
Investors in Danaher
Danaher has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Bank of America and Screenverse.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Commercial banking and asset management services are offered worldwide.
|
Founded Year | Domain | Location | |
|
Provider of advertising services
|
Founded Year | Domain | Location |
Investments & Acquisitions by Danaher
Danaher has strategically engaged in corporate development activities, having acquired 46 companies. Notable acquisitions include AVT, Abcam and Aldevron.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Instruments, kits, and reagents for nanomedicine development are manufactured.
|
2010 | ||||
|
X-ray technology applications used in dental imaging
|
2005 | ||||
|
Network packet broker based monitoring & security solution
|
2003 |
Financial Statements - Danaher
Danaher Comparisons
Competitors of Danaher
Danaher operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GE Healthcare, Medtronic, Boston Scientific, CONMED and Johnson & Johnson, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Materials management solutions are provided for healthcare organizations.
|
|
| domain | founded_year | HQ Location |
Medical equipment for treating over 30 chronic diseases is developed.
|
|
| domain | founded_year | HQ Location |
Wide range of medical devices
|
|
| domain | founded_year | HQ Location |
Surgical instruments are manufactured for multiple therapeutic areas.
|
|
| domain | founded_year | HQ Location |
Healthcare solutions are provided by Johnson & Johnson globally.
|
|
| domain | founded_year | HQ Location |
Complex healthcare challenges are addressed through technology solutions by Commure.
|
Frequently Asked Questions about Danaher
Danaher was founded in 1969 and raised its 1st funding round 32 years after it was founded.
Danaher is headquartered in Washington, United States. It is registered at Washington, District Of Columbia, United States.
Rainer Blair is the current CEO of Danaher.
As of Dec 31, 2024, the latest employee count at Danaher is 63,000.
Annual revenue of Danaher is $24.57B as on Dec 31, 2025.
RD company focused on manufacturing dental equipment for multiple therapeutic areas. Its other products include medical consumables, water quality analysis instruments, life science research instruments, and diagnostic tools. In 2021, the company recorded annual revenues of 22.28B and a net profit of 3.64B. In 2022, the company recorded annual revenues of 31.47B and a net profit of 7.2B.
Danaher's top competitors include GE Healthcare, Medtronic and Boston Scientific.
Danaher offers Biotechnology Services, Diagnostics Tools, and Life Sciences Technologies.
Yes, Danaher is publicly traded on NYSE under the ticker symbol DHR.
Danaher has 2 investors. Key investors include Bank of America, and Screenverse.
The ticker symbol of Danaher is DHR on NYSE.